Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Clinical trial NCT05564650 · COMPLETED

Trial details

NCT number: NCT05564650
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Recurrent Myelodysplastic Syndrome Refractory Myelodysplastic Syndrome

Start date: 2023-01-12
Primary completion: 2024-05-03
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.